FDA Bans Darvocet & Darvon (Propoxyphene) from Market

The FDA removed Darvocet & Darvon from the market on November 19th citing serious heart risk.  The FDA also warns that anyone taking these medications should call their doctor immediately.  Darvocet & Darvon contain the opioid propoxyphene, which is used to treat mild to moderate pain.  Darvocet combines both propoxyphene and acetaminophen and is the generic version of the branded drug, Darvon.  There are also other generic versions containing propoxyphene. 

The FDA is stating that there is now data showing that the use of propoxyphene can be damaging to the heart by causing “significant changes to the electrical activity of the heart” that can seriously affect heart rhythms and even cause sudden death. The better news being that apparently “once patients stop taking propoxyphene, the risk will go away.”

To view the full press release and to watch the video from the FDA website, please visit the link below. 

Please comment if you will be affected by this ban and are worried about what you will do now for pain relief for your Fibromyalgia and/or CFS. 

FDA NEWS RELEASE: Xanodyne agrees to withdraw propoxyphene from the U.S. market

If you liked this article, please share.
Share on Facebook0Tweet about this on TwitterShare on Google+0Share on StumbleUpon0Email this to someone

Join the Discussion.

We'd love to hear from you - leave a comment below